Photo of Solange Peters taken from Stephen V Liu/Twitter
Oct 24, 2023, 13:45
Stephen V Liu: ESMO23 – Dr. Solange Peters presents the PERLA randomized phase II study
Quoting Stephen V Liu, Associate Professor of Medicine and the Director of Thoracic Oncology at Georgetown University, on X/Twitter:
“ESMO23 – Dr. Solange Peters presents the PERLA randomized phase II study comparing two PD-1 inhibitors in NSCLC. Dostarlimab + chemotherapy versus pembrolizumab + chemotherapy. Some differences in dostarlimab binding – will that translate to an OS difference?”
Source: Stephen V Liu/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 22:40
Dec 21, 2024, 22:37
Dec 21, 2024, 22:26
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19